Key result
Three pediatric patients with acute lymphoblastic leukemia developed very severe hypertriglyceridemia, which was managed with various strategies including very-low-fat diet, insulin, and fibrates.
Why the study?
Severe and very severe hypertriglyceridemia can complicate pediatric oncology chemotherapy, but minimal literature exists to guide management and pediatricians must rely on anecdotal experiences.
How should very severe hypertriglyceridemia be managed in pediatric patients undergoing treatment for acute lymphoblastic leukemia?
Case Report (n=3)
How should very severe hypertriglyceridemia be managed in pediatric patients undergoing treatment for acute lymphoblastic leukemia?
In pediatric patients with severe hypertriglyceridemia secondary to acute lymphoblastic leukemia treatment, initial management with a very-low-fat diet may be preferable to NPO in the absence of pancreatitis.
May warrant lipid monitoring in pediatric ALL; hypothesis-generating for management and requires prospective validation.
OBJECTIVES: Severe and very severe hypertriglyceridemia although rare within the pediatric population occur more often among oncology patients, secondary to chemotherapeutic agents. Currently there exists minimal literature to guide management of severe hypertriglyceridemia among pediatric patients. Very-low-fat dietary restriction should be considered over nil per os (NPO) for initial management of severe hypertriglyceridemia in stable pediatric patients. Pediatricians caring for oncology patients must consider chylomicronemia as a potential etiology for presenting symptoms. Pediatric severe hypertriglyceridemia management guidelines are needed as pediatricians must currently rely on anecdotal experiences for management decisions. CASE PRESENTATION: Three children receiving treatment for acute lymphoblastic leukemia required hospitalization for very severe hypertriglyceridemia. Management varied among the cases but included: NPO or very-low-fat diet, insulin, intravenous fluids, fibrates, and omega-3 fatty acids. CONCLUSIONS: These cases suggest that pediatric severe hypertriglyceridemia management, in the absence of pancreatitis should allow a very-low-fat diet initially rather than NPO followed by pharmacologic therapies.
No takes yet. Share an insight, caveat, or question.
Baxter et al. (2023) conducted a case report in Very severe hypertriglyceridemia complicating acute lymphoblastic leukemia (n=3). Management strategies (NPO, very-low-fat diet, insulin, intravenous fluids, fibrates, omega-3 fatty acids) was evaluated. Three pediatric patients with acute lymphoblastic leukemia developed very severe hypertriglyceridemia, which was managed with various strategies including very-low-fat diet, insulin, and fibrates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: